TERF2 and acute promyelocytic leukemia: Finally, chemotherapeutic drugs such as arsenic trioxide (As2O3), clinically employed in the treatment of acute promyelocytic leukemia (APL), or the TopoI camptothecin, were shown to downregulate TRF2 levels [125,126].